These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28225924)

  • 1. [Not Available].
    Méndez-Alburez LP; Cerón A
    Salud Publica Mex; 2016; 58(6):587-588. PubMed ID: 28225924
    [No Abstract]   [Full Text] [Related]  

  • 2. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
    Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
    AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
    [No Abstract]   [Full Text] [Related]  

  • 3. Health priorities gain patent reprieve for developing countries.
    Cherry M
    Nature; 2001 Nov; 414(6862):385. PubMed ID: 11719767
    [No Abstract]   [Full Text] [Related]  

  • 4. WTO deadlines: why developing countries must act now to protect access to medicines.
    Dinh K
    Sex Health; 2004; 1(2):63-4. PubMed ID: 16334985
    [No Abstract]   [Full Text] [Related]  

  • 5. A trade agreement's impact on access to generic drugs.
    Shaffer ER; Brenner JE
    Health Aff (Millwood); 2009; 28(5):w957-68. PubMed ID: 19706626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lack of bioavailability of generic lopinavir/ritonavir not prequalified by WHO marketed in Africa (Congo Brazzaville)].
    Camara S; Zucman D; Vasse M; Goudjo A; Guillard E; Peytavin G
    Bull Soc Pathol Exot; 2015 Feb; 108(1):46-8. PubMed ID: 25256250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Academics should use their intellectual property to produce cheap drugs for poor countries.
    Watts G
    BMJ; 2007 May; 334(7603):1079. PubMed ID: 17525425
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma concentrations of generic lopinavir/ritonavir in HIV type-1-infected individuals.
    van der Lugt J; Lange J; Avihingsanon A; Ananworanich J; Sealoo S; Burger D; Gorowara M; Phanuphak P; Ruxrungtham K
    Antivir Ther; 2009; 14(7):1001-4. PubMed ID: 19918104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abbott's AIDS fight-back.
    Check E
    Nature; 2007 Jul; 448(7149):14. PubMed ID: 17611514
    [No Abstract]   [Full Text] [Related]  

  • 10. Abbott agrees to expand access to Kaletra/Aluvia.
    AIDS Patient Care STDS; 2007 May; 21(5):366. PubMed ID: 17518529
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of the trade-related aspects of intellectual property rights (TRIPS) agreement on India as a supplier of generic antiretrovirals.
    Babovic S; Wasan KM
    J Pharm Sci; 2011 Mar; 100(3):816-21. PubMed ID: 20740678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IP litigation in China could drive innovation.
    Jia H
    Nat Biotechnol; 2004 Apr; 22(4):368. PubMed ID: 15060539
    [No Abstract]   [Full Text] [Related]  

  • 13. WTO takes a first step.
    Lancet; 2003 Sep; 362(9386):753. PubMed ID: 13678862
    [No Abstract]   [Full Text] [Related]  

  • 14. Production of low cost AIDS drugs to continue in Brazil.
    Reprod Health Matters; 2001 Nov; 9(18):178. PubMed ID: 11803899
    [No Abstract]   [Full Text] [Related]  

  • 15. Why are generic drugs being held up in transit? Intellectual property rights, international trade, and the right to health in Brazil and beyond.
    Rosina MS; Shaver L
    J Law Med Ethics; 2012; 40(2):197-205. PubMed ID: 22789040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep less in Seattle.
    Lancet; 1999 Dec; 354(9194):1917. PubMed ID: 10622287
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioavailability of generic ritonavir and lopinavir/ritonavir tablet products in a dog model.
    Garren KW; Rahim S; Marsh K; Morris JB
    J Pharm Sci; 2010 Feb; 99(2):626-31. PubMed ID: 19230020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIPS: whose interests are being served?
    Kamal M; Bailey M
    Lancet; 2003 Jul; 362(9380):260. PubMed ID: 12892952
    [No Abstract]   [Full Text] [Related]  

  • 19. Elixirs of death. International organizations are working towards a global solution to address the problem of falsified and substandard medicines, but progress has stagnated.
    Weigmann K
    EMBO Rep; 2013 Jul; 14(7):597-600. PubMed ID: 23764922
    [No Abstract]   [Full Text] [Related]  

  • 20. WTO approves TRIPS amendment on importing under compulsory licensing.
    Herget G
    HIV AIDS Policy Law Rev; 2006 Apr; 11(1):23-4. PubMed ID: 16805011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.